EAM Investors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

EAM Investors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,055	Closed	-$490K	–	389
2017 Q1	$490K	Buy	4,055 +867	+27%	+$106K	0.08%	291
2016 Q4	$356K	Buy	+3,188	New	+$384K	0.05%	308
2014 Q4	–	Sell	-6,058	Closed	-$490K	–	386
2014 Q3	$490K	Sell	6,058 -944	-13%	-$83.5K	0.1%	308
2014 Q2	$751K	Buy	+7,002	New	+$487K	0.14%	310

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EAM Investors's GWPH Position: Q2 2017 in Review

EAM Investors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 4,055 shares — an estimated $490K sold.

EAM Investors first reported a position in GWPH in Q2 2014 and held it in 4 quarters. The position peaked at $751K in Q2 2014. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

EAM Investors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
EAM Investors sold 4,055 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $490K.
EAM Investors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 4 quarters.
EAM Investors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $751K in Q2 2014.
170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on EAM Investors's 13F filing for Q2 2017, filed 11 Aug 2017.